Glenmede Trust CO Na Bio Techne Corp Transaction History

Glenmede Trust CO Na

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 18, 2021	SELL	$314.62 - $411.0 $349,228 - $456,210	-1,110 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$246.9 - $321.87 $123,696 - $161,256	-501 Reduced 31.1%	1,110 $352,000
Q3 2020 Nov 16, 2020	BUY	$232.22 - $282.96 $56,197 - $68,476	242 Added 17.68%	1,611 $399,000
Q2 2020 Aug 14, 2020	BUY	$185.43 - $279.56 $136,847 - $206,315	738 Added 116.96%	1,369 $361,000
Q4 2019 Feb 12, 2020	BUY	$189.68 - $222.09 $20,106 - $23,541	106 Added 20.19%	631 $138,000
Q3 2019 Nov 14, 2019	BUY	$183.56 - $216.72 $3,671 - $4,334	20 Added 3.96%	525 $102,000
Q2 2019 Aug 13, 2019	BUY	$188.72 - $215.43 $4,718 - $5,385	25 Added 5.21%	505 $105,000
Q1 2019 May 14, 2019	BUY	$136.09 - $200.44 $38,105 - $56,123	280 Added 140.0%	480 $95,000
Q4 2018 Feb 14, 2019	SELL	$132.75 - $203.8 $117,218 - $179,955	-883 Reduced 81.53%	200 $28,000
Q3 2018 Nov 15, 2018	SELL	$147.44 - $204.11 $211,134 - $292,285	-1,432 Reduced 56.94%	1,083 $221,000
Q3 2017 Nov 14, 2017	BUY	$113.59 - $123.78 $285,678 - $311,306	2,515	2,515 $0

604

153M

171K

56.9K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $3.09B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.